Nomogram to predict disease recurrence in patients with locally advanced rectal cancer undergoing rectal surgery after neoadjuvant therapy: retrospective cohort study.
Jacques-Emmanuel SaadounHélène MeillatChristophe ZemmourSerge BrunelleAlexandra LapeyreCécile de ChaisemartinBernard LelongPublished in: BJS open (2022)
Our nomogram is a simple tool for predicting cancer recurrence in patients with locally advanced rectal cancer after neoadjuvant CRT followed by TME. It provides an individual risk prediction of recurrence to tailor surveillance.
Keyphrases
- rectal cancer
- locally advanced
- neoadjuvant chemotherapy
- phase ii study
- free survival
- lymph node metastasis
- papillary thyroid
- squamous cell carcinoma
- minimally invasive
- public health
- radiation therapy
- coronary artery bypass
- heart failure
- clinical trial
- mesenchymal stem cells
- young adults
- stem cells
- bone marrow
- percutaneous coronary intervention
- acute coronary syndrome